This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Pohang University of Science and Technology Foundation, Korea University Industry and Academy Collaboration Foundation, Posco. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Pohang, KR (2012)
- Kyungsangbukdo, KR (2012)
Company Filing History:
2 out of 1,113 
1 out of 3 
1 out of 709 Years Active: 2012
Title: Sei-Kwang Hahn: Innovator in Nucleic Acid Delivery Systems and Biopharmaceutical Formulations
Introduction
Sei-Kwang Hahn is a notable inventor based in Pohang, South Korea. He has made significant contributions to the field of biopharmaceuticals and nucleic acid delivery systems. With a total of two patents to his name, his work focuses on innovative solutions that enhance the efficacy of therapeutic applications.
Latest Patents
Hahn's latest patents include a "Nucleic acid delivery system comprising conjugates of PEI and hyaluronic acid." This invention relates to a delivery system for nucleic acids using a cationic polymer conjugate. Specifically, it involves a delivery system that comprises a cationic polymer conjugate prepared by conjugating hyaluronic acid or its derivative with polyethyleneimine. The system is designed to facilitate the delivery of nucleic acids into mammalian cells through electrostatic binding.
Another significant patent is the "Long acting formulation of biopharmaceutical." This invention pertains to a long-acting formulation of biopharmaceuticals, particularly focusing on aptamer therapeutics. The formulation involves a branched PEGylated aptamer or a hyaluronic acid derivative, with its degradation in vivo regulated through bioconjugation with biopharmaceuticals to produce a long-action formulation.
Career Highlights
Throughout his career, Sei-Kwang Hahn has worked with various institutions that emphasize collaboration between academia and industry. His experience includes positions at the Postech Academy-Industry Foundation and the Korea University Industry and Academy Collaboration Foundation. These roles have allowed him to bridge the gap between research and practical applications in the field of biopharmaceuticals.
Collaborations
Hahn has collaborated with notable colleagues such as Hyun-Gu Kang and Yu-Kyoung Oh. Their combined expertise has contributed to the advancement of innovative solutions in their respective fields.
Conclusion
Sei-Kwang Hahn's contributions to nucleic acid delivery systems and biopharmaceutical formulations highlight his role as an influential inventor. His patents reflect a commitment to advancing therapeutic technologies that can significantly impact healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile